PATENT CLAIM ANALYSIS

Application Number: 15943382
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These compositions comprise dimyristoylphosphatidylcholine (“DMPC”); either dimyristoylphosphatidylglycerol (“DMPG”) or dimyristoyltrimethylammonium propane (“DMTAP”) or both DMPC and DMTAP; and at least one sterol derivative providing a covalent anchor for one or more immunogenic polypeptide(s) or carbohydrate(s).

Claim (Index 4):
A composition according to  claim 1 , wherein said liposomes are substantially between 50 and 500 nm in diameter.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.59259
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15181028', '12720592', '14320278', '15566140', '15024600']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7099761277090995
- 35 USC 102 Novelty (BERT): 0.6083273608254541
- Combined Prediction Score: 0.699811251020735
- Mean Citation Score: 380.390576
- Max Citation Score: 512.2341
- Similarity Product: 497.3192636377216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test